Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesImpairment of NF-kB activation and modulation of gene expression by calpastatinThe familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragmentB cell adaptor containing src homology 2 domain (BASH) links B cell receptor signaling to the activation of hematopoietic progenitor kinase 1Withaferin A disrupts ubiquitin-based NEMO reorganization induced by canonical NF-κB signalingThe c-Rel transcription factor and B-cell proliferation: a deal with the devilFibromodulin suppresses nuclear factor-kappaB activity by inducing the delayed degradation of IKBA via a JNK-dependent pathway coupled to fibroblast apoptosisThe PEST domain of IkappaBalpha is necessary and sufficient for in vitro degradation by mu-calpain.C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavageRelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts.Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.Calpain as an effector of the Gq signaling pathway for inhibition of Wnt/beta -catenin-regulated cell proliferationAdvances in the understanding of familial Mediterranean fever and possibilities for targeted therapy.A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes.Up-regulation of transient receptor potential canonical 1 (TRPC1) following sarco(endo)plasmic reticulum Ca2+ ATPase 2 gene silencing promotes cell survival: a potential role for TRPC1 in Darier's disease.IPO3-mediated Nonclassical Nuclear Import of NF-κB Essential Modulator (NEMO) Drives DNA Damage-dependent NF-κB ActivationLipopolysaccharide from Salmonella enterica activates NF-kappaB through both classical and alternative pathways in primary B LymphocytesFunctional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B betaIkappaB is a substrate for a selective pathway of lysosomal proteolysis.Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells.Long-term incubation with proteasome inhibitors (PIs) induces IκBα degradation via the lysosomal pathway in an IκB kinase (IKK)-dependent and IKK-independent mannerModulation of nuclear factor-kappaB improves cardiac dysfunction associated with cardiopulmonary bypass and deep hypothermic circulatory arrest.Cyp1B1 expression promotes angiogenesis by suppressing NF-κB activity.TRIP/NOPO E3 ubiquitin ligase promotes ubiquitylation of DNA polymerase η.Selective autophagy: talking with the UPS.Suppression of erythroid but not megakaryocytic differentiation of human K562 erythroleukemic cells by notch-1.NF-kappaB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events.Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease.A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction.IkappaB kinase-dependent chronic activation of NF-kappaB is necessary for p21(WAF1/Cip1) inhibition of differentiation-induced apoptosis of monocytes.Postrepression activation of NF-kappaB requires the amino-terminal nuclear export signal specific to IkappaBalpha.Cell-specific association and shuttling of IkappaBalpha provides a mechanism for nuclear NF-kappaB in B lymphocytes.The zinc finger domain of NEMO is selectively required for NF-kappa B activation by UV radiation and topoisomerase inhibitors.Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus.A mechanistic insight into a proteasome-independent constitutive inhibitor kappaBalpha (IkappaBalpha) degradation and nuclear factor kappaB (NF-kappaB) activation pathway in WEHI-231 B-cells.Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells.Repression of activator protein-1-mediated transcriptional activation by the Notch-1 intracellular domain.Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity.High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells.Elevated calcium in preneoplastic cells activates NF-kappa B and confers resistance to apoptosis.
P2860
Q21296830-C81B4C2B-EBBE-4AC3-9E85-4DDD5938A798Q23923192-0FC843A7-45C7-49E5-8A76-2400EDCB39C2Q24642151-B5F8C6C7-06EA-4738-A07A-3D60E22F6A18Q24675505-A062D77A-5118-4021-ABDA-4F637E11FA57Q27302812-398C96CC-9AA4-48BF-A322-8AFE278AED81Q28241767-A3B61605-7B22-43BC-A4D8-39038F476ED7Q28386926-8D0B231A-0AC3-48F8-B470-EC70578EA44EQ33876994-BB350FBD-81DB-418D-8C1F-FFEC520D3CC8Q33957358-AF8AE568-3B42-422D-A7E4-974BAD84F9BCQ33960289-79F95644-CD27-404C-848C-DF69700EF272Q34182208-40001945-E9F7-495E-BE21-98E953E7C2B9Q34192418-46C09505-EDF5-4D2D-BAA3-B944837B2822Q34608120-E193E0BA-C22A-42D7-A3DF-CF19057FC728Q34997917-476E1B38-A24A-4C73-A990-6716EA13DE9FQ35128235-F74F1DBC-73A6-4E28-B778-715CB74786E4Q35859525-DFD24BD1-6A11-4A56-B77C-942A954312D3Q36097312-D4F2C81D-6506-432C-A9B6-F02ABCD46B82Q36401827-F70E0884-E303-4879-8C03-4B611518EF55Q36894842-DBC7B71B-1803-4E8E-A1BC-0216C76CDC68Q36984165-56CEFAE3-8377-4994-89E6-77104EAD1D83Q37289335-737043C4-C568-495A-9FE4-EBF39B1E50C3Q37349960-D92395AE-6754-4783-85BD-2A2C57E97698Q37439850-E5EA6219-257E-4FF2-9912-6D3F183AFB6CQ37618680-56A71866-2EFA-44AD-822E-11B813E65EBBQ38109587-78C5B95A-FD71-44A3-842C-251BBDE4B731Q38312829-8E180175-4A59-46AA-A281-5813033B5609Q38313997-28DB21D9-1EC6-4D8C-92DC-7E487C84EBEFQ38351589-F87E28FB-B7B7-48BE-8373-79762987025CQ39005586-187F4687-19C3-495D-970D-845E23F3FACFQ39458241-1D4E5CBB-A816-4AB7-A8EB-D36AC6B9AB3DQ39460041-F696FEC9-3E29-4E4C-B8A6-2A59B1B8DD08Q39460183-EE471A5D-EEA7-453B-AAAF-AE3981CAAD40Q39675214-06057C46-D4A5-48B6-9AEA-C09E3FCFA391Q40407591-1E4C9746-9A2E-47A5-8F5A-60BF036AB873Q40592420-D344C2F2-3BFF-475A-B725-A2864871AF08Q40648086-290D805F-4CEB-4D10-BA1A-73D1A7A773A7Q40764510-826A8188-E7BE-4E3A-8FAF-DD8455F4F3ADQ40778493-58481A6C-B46D-4DE6-8BC8-E2F003647E27Q40782268-9775976C-8B9E-49D9-95AE-F04D7AFCAAC7Q40789320-C348DDC6-0C1A-4789-8939-862572A11E4F
P2860
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@ast
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@en
type
label
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@ast
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@en
prefLabel
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@ast
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@en
P2093
P2860
P356
P1476
Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells.
@en
P2093
B J Seufzer
S D Shumway
S Miyamoto
P2860
P356
10.1128/MCB.18.1.19
P407
P577
1998-01-01T00:00:00Z